Product Information
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT is a generic product labeled by Prasco Laboratories, priced at $2.1929 per GM under NDC 66993093861. Its NADAC has been published 330 times since Apr 29, 2020.
FDA first approved this application on Jan 9, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT
Calcipotriene and Betamethasone DipropionateStrength
.5; 50 mg/g; ug/g
Manufacturer
Prasco LaboratoriesNDC
66993093861
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021852FDA Approved
1/9/2006
TE Code
AB
On Market Since
1/28/2020
Pharmacological Classes
Price Statistics
The NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT has been published 330 times since Apr 29, 2020, and over the history we have for it it has declined 78.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1929 per GM |
|---|---|
| All-time high | $10.0069 (May 13, 2020) |
| All-time low | $2.0221 (Nov 20, 2024) |
| 52-week high | $2.8401 |
| 52-week low | $2.1929 |
| Median price | $3.4671 |
| Average price | $4.2277 |
| Largest weekly change | +49.2% (Jan 20, 2021) |
| Weeks tracked | 330 |
| Tracking since | Apr 29, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT, manufactured by Prasco Laboratories, is $2.1929 per GM (NDC 66993093861), effective Aug 19, 2026.
How has the price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT changed over time?
Over the history we have for it, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT has declined 78.1%. It has been tracked across 330 weekly CMS publications since Apr 29, 2020.
What are the highest and lowest recorded NADAC prices for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
Since Apr 29, 2020, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT has ranged from a low of $2.0221 (Nov 20, 2024) to a high of $10.0069 (May 13, 2020), with a median of $3.4671 per GM.
Are there cheaper alternatives to CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT, is $1.4785 per GM — about 33% below CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT.
Who manufactures CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT (NDC 66993093861) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.